In the context of epidemiology, glycopeptides are crucial because they serve as a last line of defense against multi-drug resistant organisms. The emergence of antibiotic-resistant bacteria poses a significant public health challenge, and glycopeptides are often used to manage outbreaks of resistant infections. Understanding their use and limitations helps in developing antimicrobial stewardship programs aimed at curbing resistance.
